<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 15 Apr 2026 01:57:19 -0400--><rss version="2.0">
    <channel>
        <title>Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings</title>
        <link>https://ir.acurxpharma.com/quarterly-reports/rss</link>
        <description>Acurx Pharmaceuticals, Inc. (ACXP) - Quarterly Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_54f3e0bf8d6456169cd25706f74b6503/acurxpharma/logo.png</url>
                <title>Acurx Pharmaceuticals, Inc. Logo</title>
                <link>https://ir.acurxpharma.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-461-0001104659-25-109698</link>
                <pubDate>Wed, 12 Nov 25 07:01:16 -0500</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-461-0001104659-25-109698</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-444-0001558370-25-011045</link>
                <pubDate>Mon, 11 Aug 25 16:07:05 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-444-0001558370-25-011045</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-395-0001558370-25-007371</link>
                <pubDate>Mon, 12 May 25 16:08:59 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-395-0001558370-25-007371</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-325-0001558370-24-015310</link>
                <pubDate>Tue, 12 Nov 24 16:06:59 -0500</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-325-0001558370-24-015310</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-318-0001558370-24-011587</link>
                <pubDate>Thu, 08 Aug 24 16:11:23 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-318-0001558370-24-011587</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-305-0001558370-24-008130</link>
                <pubDate>Tue, 14 May 24 16:08:46 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-305-0001558370-24-008130</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-260-0001558370-23-018824</link>
                <pubDate>Mon, 13 Nov 23 16:12:49 -0500</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-260-0001558370-23-018824</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-243-0001558370-23-014645</link>
                <pubDate>Fri, 11 Aug 23 16:56:08 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-243-0001558370-23-014645</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-211-0001558370-23-009495</link>
                <pubDate>Fri, 12 May 23 07:55:46 -0400</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-211-0001558370-23-009495</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.acurxpharma.com/quarterly-reports?page=1#document-180-0001558370-22-017408</link>
                <pubDate>Thu, 10 Nov 22 16:59:35 -0500</pubDate>
                <guid isPermalink="true">https://ir.acurxpharma.com/quarterly-reports?page=1#document-180-0001558370-22-017408</guid>
                                                                            </item>
            </channel>
</rss>